| Dr Nicole Amber Berry Schick, MD | |
|
2700 Northup Way, Bellevue, WA 98004-1463 | |
| (425) 827-4600 | |
| (425) 828-2256 |
| Full Name | Dr Nicole Amber Berry Schick |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 2700 Northup Way, Bellevue, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720214513 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 40115 (Iowa) | Secondary |
| 208000000X | Pediatrics | R-8685 (Iowa) | Secondary |
| 208000000X | Pediatrics | MD 60624082 (Washington) | Primary |
| Entity Name | Swedish Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831139724 PECOS PAC ID: 9537072814 Enrollment ID: O20031112000189 |
News Archive
Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone payment from Boehringer Ingelheim, one of the world's 20 leading pharmaceutical companies. Vitae's 11beta-hydroxysteroid dehydrogenase (HSD)-1 is targeted for the treatment of diabetes and metabolic syndrome-related diseases in a strategic alliance with Boehringer Ingelheim. The payment recognizes Boehringer Ingelheim's recent advancement of a small molecule inhibitor of 11beta-HSD-1 into Phase I clinical trials.
Sleeping too little or even too much has been associated with several disease conditions including metabolic syndrome that predisposes a person to develop diabetes, stroke and heart disease. The findings of the study titled, "Association between sleep duration and metabolic syndrome: a cross-sectional study," was published in the latest issue of the journal BMC Public Health.
The environmental impact of millions of gallons of oil still in the Gulf of Mexico from the Deepwater Horizon incident may depend on microscopic helpers: Bacteria that consume oil and other hydrocarbons and could break down the spilled crude, making it disappear. That's the topic of an article in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.
Giving intravenous beta blockers before performing a coronary angioplasty in patients who had experienced the deadliest form of heart attack—ST-segment elevation myocardial infarction (STEMI)—was safe but did not reduce heart attack severity or improve blood flow from the heart's main pumping chamber, according to research presented at the American College of Cardiology's 65th Annual Scientific Session.
Ophthotech Corporation today announced that data from a large, prospective, randomized, controlled Phase 2b clinical trial of Ophthotech's Fovista anti-PDGF therapy (1.5 mg) in patients with neovascular age-related macular degeneration (wet AMD) will be presented during Retina Subspecialty Day at the American Academy of Ophthalmology Annual Meeting (AAO) on Sat., Nov. 10, 2012 at 9:15 a.m.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nicole Amber Berry Schick, MD 2700 Northup Way, Bellevue, WA 98004-1463 Ph: (425) 827-4600 | Dr Nicole Amber Berry Schick, MD 2700 Northup Way, Bellevue, WA 98004-1463 Ph: (425) 827-4600 |
News Archive
Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone payment from Boehringer Ingelheim, one of the world's 20 leading pharmaceutical companies. Vitae's 11beta-hydroxysteroid dehydrogenase (HSD)-1 is targeted for the treatment of diabetes and metabolic syndrome-related diseases in a strategic alliance with Boehringer Ingelheim. The payment recognizes Boehringer Ingelheim's recent advancement of a small molecule inhibitor of 11beta-HSD-1 into Phase I clinical trials.
Sleeping too little or even too much has been associated with several disease conditions including metabolic syndrome that predisposes a person to develop diabetes, stroke and heart disease. The findings of the study titled, "Association between sleep duration and metabolic syndrome: a cross-sectional study," was published in the latest issue of the journal BMC Public Health.
The environmental impact of millions of gallons of oil still in the Gulf of Mexico from the Deepwater Horizon incident may depend on microscopic helpers: Bacteria that consume oil and other hydrocarbons and could break down the spilled crude, making it disappear. That's the topic of an article in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.
Giving intravenous beta blockers before performing a coronary angioplasty in patients who had experienced the deadliest form of heart attack—ST-segment elevation myocardial infarction (STEMI)—was safe but did not reduce heart attack severity or improve blood flow from the heart's main pumping chamber, according to research presented at the American College of Cardiology's 65th Annual Scientific Session.
Ophthotech Corporation today announced that data from a large, prospective, randomized, controlled Phase 2b clinical trial of Ophthotech's Fovista anti-PDGF therapy (1.5 mg) in patients with neovascular age-related macular degeneration (wet AMD) will be presented during Retina Subspecialty Day at the American Academy of Ophthalmology Annual Meeting (AAO) on Sat., Nov. 10, 2012 at 9:15 a.m.
› Verified 7 days ago
Eric Albert Gustafson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2700 Northup Way, Bellevue, WA 98004 Phone: 425-827-4600 | |
Dr. Arlene Elizabeth Ritzen, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1900 116th Ave Ne, Bellevue, WA 98004 Phone: 425-453-0404 | |
Dr. Emily Susan Showman, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3633 136th Place Se, Suite #110, Bellevue, WA 98006 Phone: 425-747-7202 Fax: 425-643-0635 | |
Ildiko Hegyvary Thomas, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 | |
Bill M Fournarakis, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2700 Northup Way, Bellevue, WA 98004 Phone: 425-827-4600 Fax: 425-828-2256 | |
Irene Hwang, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3633 136th Place Se, Suite #110, Bellevue, WA 98006 Phone: 425-747-7202 Fax: 425-643-0635 | |
Pamela Laborde, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3633 136th Place Se, Suite #110, Bellevue, WA 98006 Phone: 425-747-7202 Fax: 425-643-0635 |